98 related articles for article (PubMed ID: 8867484)
21. Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis.
McVeigh GE; Allen PB; Morgan DR; Hanratty CG; Silke B
Clin Sci (Lond); 2001 Apr; 100(4):387-93. PubMed ID: 11256976
[TBL] [Abstract][Full Text] [Related]
22. Antithrombotic effect of L-arginine in hypertensive rats.
Cylwik D; Mogielnicki A; Kramkowski K; Stokowski J; Buczko W
J Physiol Pharmacol; 2004 Sep; 55(3):563-74. PubMed ID: 15381827
[TBL] [Abstract][Full Text] [Related]
23. Streptokinase-prostacyclin--nitric oxide: in vivo interactions.
Gryglewski RJ; Swies J
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():479-84. PubMed ID: 7537438
[No Abstract] [Full Text] [Related]
24. L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
Cassone Faldetta M; Laurenti O; Desideri G; Bravi MC; De Luca O; Marinucci MC; De Mattia G; Ferri C
Diabetologia; 2002 Aug; 45(8):1120-7. PubMed ID: 12189442
[TBL] [Abstract][Full Text] [Related]
25. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
Schweiger H; Ortmeier CJ
Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
[TBL] [Abstract][Full Text] [Related]
26. [Endothelial dysfunction in peripheral arterial occlusive disease: from basic research to clinical use].
Böger RH; Bode-Böger SM
Vasa; 1997 Aug; 26(3):180-4. PubMed ID: 9381783
[TBL] [Abstract][Full Text] [Related]
27. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
[TBL] [Abstract][Full Text] [Related]
28. Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease.
Darius H; Kopp H; Mulfinger A; Spielberger M; Todt M; Schuster CJ; Meyer J
Prog Clin Biol Res; 1989; 301():417-21. PubMed ID: 2508112
[No Abstract] [Full Text] [Related]
29. Prolonged infusion of prostacyclin in patients with advanced stages of peripheral vascular disease: a placebo-controlled cross-over study.
Hossmann V; Auel H; Rücker W; Schrör K
Klin Wochenschr; 1984 Dec; 62(23):1108-14. PubMed ID: 6394890
[TBL] [Abstract][Full Text] [Related]
30. Decrease of fibrinogen in patients with peripheral atherosclerotic disease by ticlopidine.
Randi ML; Mares M; Fabris F; Tison T; Barbone E; Girolami A
Arzneimittelforschung; 1991 Apr; 41(4):414-6. PubMed ID: 1859515
[TBL] [Abstract][Full Text] [Related]
31. L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release.
Marietta M; Facchinetti F; Neri I; Piccinini F; Volpe A; Torelli G
Thromb Res; 1997 Oct; 88(2):229-35. PubMed ID: 9361375
[TBL] [Abstract][Full Text] [Related]
32. [Experiences with ultra-high dosage fibrinolysis in arterial occlusive disease].
Redecker M; Heinrich F; Fenn K
Vasa Suppl; 1988; 23():182-5. PubMed ID: 3206334
[No Abstract] [Full Text] [Related]
33. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
Racenberg J; Intaglietta M; Messmer K
Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
[TBL] [Abstract][Full Text] [Related]
34. L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study.
Bode-Böger SM; Böger RH; Alfke H; Heinzel D; Tsikas D; Creutzig A; Alexander K; Frölich JC
Circulation; 1996 Jan; 93(1):85-90. PubMed ID: 8616947
[TBL] [Abstract][Full Text] [Related]
35. Relief of chronic peripheral artery obstruction by intravenous Brinase.
Frisch EP; Fitzgerald DE
J Ir Med Assoc; 1973 Jun; 66(12):313-8. PubMed ID: 4721370
[No Abstract] [Full Text] [Related]
36. Glutathione (GSH) improved haemostatic and haemorheological parameters in atherosclerotic subjects.
Coppola L; Grassia A; Giunta R; Verrazzo G; Cava B; Tirelli A; D'Onofrio F
Drugs Exp Clin Res; 1992; 18(11-12):493-8. PubMed ID: 1308476
[TBL] [Abstract][Full Text] [Related]
37. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease.
Bielawiec M; Lukjan H; Kiersnowska-Rogowska B; Dabrowski S
Bibl Anat; 1979; (18):378-81. PubMed ID: 496871
[No Abstract] [Full Text] [Related]
38. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
Paoletti V; Mammarella A; Alessandrini A; Barlattani M
Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
[No Abstract] [Full Text] [Related]
39. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
Horsch S
Vasa Suppl; 1988; 24():38-43. PubMed ID: 3212602
[No Abstract] [Full Text] [Related]
40. Effects of intravenous administration of L-arginine on autonomic nervous activities. Analysis of heart rate variability.
Nomura M; Nakaya Y; Nada T; Endo J; Kondo Y; Yukinaka M; Saito K; Ito S
Jpn Heart J; 1998 May; 39(3):331-8. PubMed ID: 9711184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
